1 2 3 4 5 6 7 8 9

читать далее ... diatrics. Subcommittee on Management of Sinusitis and Committee on duality Improvement. Clinical practice guideline: management ofsinusitis. Pediatrics 2001:108:798 -808. 9. Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J. 1999:18:1-9.10. Harris JA, KolokathisA, CampbellM, CasselIGH, Hammerschlag MR. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr Infect Dis J. 1998:17:865-871. 11. Mclntosh К. Community-acquired pneumonia in children. N EngI J Med. 2002:346:429-437. 12. Amsden GW. Pneumococcal macrolide resistance: myth or reality?J Antimicrob Chemother. 1999:44:1-6. 13. Doern GV. Antimicrobial resistance with Streptococcus pneumonlae: much ado about nothing?Semin Respir Infect. 2001:16:177-185. 14. LonksJR, GarauJ, GomezL, etal. Failure of'macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin Infect Dis. 2002:35:556 -564. 15. Musher DM, Dowell ME, Shortridge VD, ef al. Emergence of macrolide resistance during treatment of pneumococcal pneumonia.. N EngI J Med. 2002:346:630 -631. 16. Dowell SF, Smith T, Leversedge K, Snitzer J. Failure of treatment of pneumonia associated with highly resistant pneumococci in a child. Clin Infect Dis. 1999:29:462-463. 17. Daum RS, Nachman JP, Leitch CD, Tenover FC. Nosocomial epiglottitis associated with penicillin- and cephalosporin-resistant Streptococcus pneumoniae bacteremia. J Clin Microbiol 1994:32:246 -248. 18. Chesney PJ, Davis Y, English BK, Wang WC. Occurrence of Streptococcus pneumoniae meningitis during vancomycin and cefotaxime therapy ofsepticemia in a patient with sickle cell disease. Pediatr Infect Dis J. 1995:14:1013-1015. 19. Buckingham SC, Brown SP, Joaquin VH. Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia. J Pediatr. 1998:132:174-176. 20. Shortridge VD, Doern GV, Brueggemann AB, Beyer JM, Flamm RK. Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a mult/center antibiotic resistance surveillance study conducted in the United States in 1994 -1995. Clin Infect Dis. 1999:29:1186-1188. 21. KelleyMA, Weber DJ, Gilligan P, Cohen MS. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. Clin Infect Dis. 2000:31:1008-1011. 22. Fogarty С, Goldschmidt R, Bush K. Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levotloxacin. Clin Infect Dis. 2000:31:613-615. 23. Field FtJr, Bradley JS, Hindler J. Pneumococcal meningitis during therapy of otitis , media with clarithromycin. Pediatr Infect Dis J. 1995:14:1104 -1105. 24 Jackson MA, Burry VF, Olson LC, Duthie SE, KearnИсточник: Белобородов В.Б. Русский медицинский журнал. 2006. Т.14. №7. С.530-535